M. Masud and U. Usman, “Indacaterol/ Glycopyrronium in Symptomatic Patients with COPD (GOLD 2 and GOLD 3) Versus Salmeterol/ Fluticasone”, IJBR, vol. 3, no. 4, pp. 614–617, Apr. 2025.